← 產業報告目錄
Pertussis Vaccine Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-08頁數 115報告編號 APO-e21d9cdf1d
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Global pertussis vaccine key players include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology etc. Global top 2 manufacturers hold a share about 90%. Europe is the largest market, with a share over 30%, followed by North America.
Report Scope
This report quantifies the global Pertussis Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (M Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pertussis Vaccine Market by Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Wuhan Institute of Biological Products
Walvax Biotechnology
Minhai Biotechnology
KM Biologics
Chengdu Institute of Biological Products
Pertussis Vaccine Segment by Type
Whole-cell Vaccines
Acellular Vaccines
Pertussis Vaccine Segment by Application
12 Months Below
12 Months Above
Pertussis Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pertussis Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pertussis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pertussis Vaccine Market Size (2021-2032)
2.2.2 Global Pertussis Vaccine Sales (2021-2032)
2.2.3 Global Pertussis Vaccine Market Average Price (2021-2032)
2.3 Pertussis Vaccine by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Whole-cell Vaccines
2.3.3 Acellular Vaccines
2.4 Pertussis Vaccine by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 12 Months Below
2.4.3 12 Months Above
3 Market Competitive Landscape by Manufacturers
3.1 Global Pertussis Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Pertussis Vaccine Sales (M Doses) of Manufacturers (2021-2026)
3.3 Global Pertussis Vaccine Revenue of Manufacturers (2021-2026)
3.4 Global Pertussis Vaccine Average Price by Manufacturers (2021-2026)
3.5 Global Pertussis Vaccine Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pertussis Vaccine, Product Type & Application
3.8 Global Manufacturers of Pertussis Vaccine, Established Date
3.9 Global Pertussis Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Company Information
4.1.2 Sanofi Pasteur Business Overview
4.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
4.1.5 Sanofi Pasteur Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.2.4 GSK Pertussis Vaccine Product Portfolio
4.2.5 GSK Recent Developments
4.3 Mitsubishi Tanabe Pharma
4.3.1 Mitsubishi Tanabe Pharma Company Information
4.3.2 Mitsubishi Tanabe Pharma Business Overview
4.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
4.3.5 Mitsubishi Tanabe Pharma Recent Developments
4.4 Wuhan Institute of Biological Products
4.4.1 Wuhan Institute of Biological Products Company Information
4.4.2 Wuhan Institute of Biological Products Business Overview
4.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
4.4.5 Wuhan Institute of Biological Products Recent Developments
4.5 Walvax Biotechnology
4.5.1 Walvax Biotechnology Company Information
4.5.2 Walvax Biotechnology Business Overview
4.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
4.5.5 Walvax Biotechnology Recent Developments
4.6 Minhai Biotechnology
4.6.1 Minhai Biotechnology Company Information
4.6.2 Minhai Biotechnology Business Overview
4.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
4.6.5 Minhai Biotechnology Recent Developments
4.7 KM Biologics
4.7.1 KM Biologics Company Information
4.7.2 KM Biologics Business Overview
4.7.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.7.4 KM Biologics Pertussis Vaccine Product Portfolio
4.7.5 KM Biologics Recent Developments
4.8 Chengdu Institute of Biological Products
4.8.1 Chengdu Institute of Biological Products Company Information
4.8.2 Chengdu Institute of Biological Products Business Overview
4.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
4.8.5 Chengdu Institute of Biological Products Recent Developments
5 Global Pertussis Vaccine Market Scenario by Region
5.1 Global Pertussis Vaccine Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Pertussis Vaccine Sales by Region: 2021-2032
5.2.1 Global Pertussis Vaccine Sales by Region: 2021-2026
5.2.2 Global Pertussis Vaccine Sales by Region: 2027-2032
5.3 Global Pertussis Vaccine Revenue by Region: 2021-2032
5.3.1 Global Pertussis Vaccine Revenue by Region: 2021-2026
5.3.2 Global Pertussis Vaccine Revenue by Region: 2027-2032
5.4 North America Pertussis Vaccine Market Facts & Figures by Country
5.4.1 North America Pertussis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Pertussis Vaccine Sales by Country (2021-2032)
5.4.3 North America Pertussis Vaccine Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Pertussis Vaccine Market Facts & Figures by Country
5.5.1 Europe Pertussis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Pertussis Vaccine Sales by Country (2021-2032)
5.5.3 Europe Pertussis Vaccine Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Pertussis Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Pertussis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Pertussis Vaccine Sales by Country (2021-2032)
5.6.3 Asia Pacific Pertussis Vaccine Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Pertussis Vaccine Market Facts & Figures by Country
5.7.1 South America Pertussis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Pertussis Vaccine Sales by Country (2021-2032)
5.7.3 South America Pertussis Vaccine Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Pertussis Vaccine Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Pertussis Vaccine Sales by Country (2021-2032)
5.8.3 Middle East and Africa Pertussis Vaccine Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Pertussis Vaccine Sales by Type (2021-2032)
6.1.1 Global Pertussis Vaccine Sales by Type (2021-2032) & (M Doses)
6.1.2 Global Pertussis Vaccine Sales Market Share by Type (2021-2032)
6.2 Global Pertussis Vaccine Revenue by Type (2021-2032)
6.2.1 Global Pertussis Vaccine Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Pertussis Vaccine Revenue Market Share by Type (2021-2032)
6.3 Global Pertussis Vaccine Price by Type (2021-2032)
7 Segment by Application
7.1 Global Pertussis Vaccine Sales by Application (2021-2032)
7.1.1 Global Pertussis Vaccine Sales by Application (2021-2032) & (M Doses)
7.1.2 Global Pertussis Vaccine Sales Market Share by Application (2021-2032)
7.2 Global Pertussis Vaccine Revenue by Application (2021-2032)
7.2.1 Global Pertussis Vaccine Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Pertussis Vaccine Revenue Market Share by Application (2021-2032)
7.3 Global Pertussis Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Pertussis Vaccine Value Chain Analysis
8.1.1 Pertussis Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pertussis Vaccine Production Mode & Process
8.2 Pertussis Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pertussis Vaccine Distributors
8.2.3 Pertussis Vaccine Customers
9 Global Pertussis Vaccine Analyzing Market Dynamics
9.1 Pertussis Vaccine Industry Trends
9.2 Pertussis Vaccine Industry Drivers
9.3 Pertussis Vaccine Industry Opportunities and Challenges
9.4 Pertussis Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Pertussis Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Pertussis Vaccine Sales (M Doses) of Manufacturers (2021-2026)
Table 7. Global Pertussis Vaccine Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Pertussis Vaccine Revenue of Manufacturers (2021-2026)
Table 9. Global Pertussis Vaccine Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Pertussis Vaccine Average Price (USD/Doses) of Manufacturers (2021-2026)
Table 11. Global Pertussis Vaccine Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Pertussis Vaccine, Product Type & Application
Table 14. Global Pertussis Vaccine Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Pertussis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Sanofi Pasteur Company Information
Table 19. Sanofi Pasteur Business Overview
Table 20. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 21. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 22. Sanofi Pasteur Recent Developments
Table 23. GSK Company Information
Table 24. GSK Business Overview
Table 25. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 26. GSK Pertussis Vaccine Product Portfolio
Table 27. GSK Recent Developments
Table 28. Mitsubishi Tanabe Pharma Company Information
Table 29. Mitsubishi Tanabe Pharma Business Overview
Table 30. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 31. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 32. Mitsubishi Tanabe Pharma Recent Developments
Table 33. Wuhan Institute of Biological Products Company Information
Table 34. Wuhan Institute of Biological Products Business Overview
Table 35. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 36. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 37. Wuhan Institute of Biological Products Recent Developments
Table 38. Walvax Biotechnology Company Information
Table 39. Walvax Biotechnology Business Overview
Table 40. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 41. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 42. Walvax Biotechnology Recent Developments
Table 43. Minhai Biotechnology Company Information
Table 44. Minhai Biotechnology Business Overview
Table 45. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 46. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 47. Minhai Biotechnology Recent Developments
Table 48. KM Biologics Company Information
Table 49. KM Biologics Business Overview
Table 50. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 51. KM Biologics Pertussis Vaccine Product Portfolio
Table 52. KM Biologics Recent Developments
Table 53. Chengdu Institute of Biological Products Company Information
Table 54. Chengdu Institute of Biological Products Business Overview
Table 55. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026)
Table 56. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 57. Chengdu Institute of Biological Products Recent Developments
Table 58. Global Pertussis Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 59. Global Pertussis Vaccine Sales by Region (2021-2026) & (M Doses)
Table 60. Global Pertussis Vaccine Sales Market Share by Region (2021-2026)
Table 61. Global Pertussis Vaccine Sales by Region (2027-2032) & (M Doses)
Table 62. Global Pertussis Vaccine Sales Market Share by Region (2027-2032)
Table 63. Global Pertussis Vaccine Revenue by Region (2021-2026) & (US$ Million)
Table 64. Global Pertussis Vaccine Revenue Market Share by Region (2021-2026)
Table 65. Global Pertussis Vaccine Revenue by Region (2027-2032) & (US$ Million)
Table 66. Global Pertussis Vaccine Revenue Market Share by Region (2027-2032)
Table 67. North America Pertussis Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 68. North America Pertussis Vaccine Sales by Country (2021-2026) & (M Doses)
Table 69. North America Pertussis Vaccine Sales by Country (2027-2032) & (M Doses)
Table 70. North America Pertussis Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 71. North America Pertussis Vaccine Revenue by Country (2027-2032) & (US$ Million)
Table 72. Europe Pertussis Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 73. Europe Pertussis Vaccine Sales by Country (2021-2026) & (M Doses)
Table 74. Europe Pertussis Vaccine Sales by Country (2027-2032) & (M Doses)
Table 75. Europe Pertussis Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 76. Europe Pertussis Vaccine Revenue by Country (2027-2032) & (US$ Million)
Table 77. Asia Pacific Pertussis Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 78. Asia Pacific Pertussis Vaccine Sales by Country (2021-2026) & (M Doses)
Table 79. Asia Pacific Pertussis Vaccine Sales by Country (2027-2032) & (M Doses)
Table 80. Asia Pacific Pertussis Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 81. Asia Pacific Pertussis Vaccine Revenue by Country (2027-2032) & (US$ Million)
Table 82. South America Pertussis Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 83. South America Pertussis Vaccine Sales by Country (2021-2026) & (M Doses)
Table 84. South America Pertussis Vaccine Sales by Country (2027-2032) & (M Doses)
Table 85. South America Pertussis Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 86. South America Pertussis Vaccine Revenue by Country (2027-2032) & (US$ Million)
Table 87. Middle East and Africa Pertussis Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 88. Middle East and Africa Pertussis Vaccine Sales by Country (2021-2026) & (M Doses)
Table 89. Middle East and Africa Pertussis Vaccine Sales by Country (2027-2032) & (M Doses)
Table 90. Middle East and Africa Pertussis Vaccine Revenue by Country (2021-2026) & (US$ Million)
Table 91. Middle East and Africa Pertussis Vaccine Revenue by Country (2027-2032) & (US$ Million)
Table 92. Global Pertussis Vaccine Sales by Type (2021-2026) & (M Doses)
Table 93. Global Pertussis Vaccine Sales by Type (2027-2032) & (M Doses)
Table 94. Global Pertussis Vaccine Sales Market Share by Type (2021-2026)
Table 95. Global Pertussis Vaccine Sales Market Share by Type (2027-2032)
Table 96. Global Pertussis Vaccine Revenue by Type (2021-2026) & (US$ Million)
Table 97. Global Pertussis Vaccine Revenue by Type (2027-2032) & (US$ Million)
Table 98. Global Pertussis Vaccine Revenue Market Share by Type (2021-2026)
Table 99. Global Pertussis Vaccine Revenue Market Share by Type (2027-2032)
Table 100. Global Pertussis Vaccine Price by Type (2021-2026) & (USD/Doses)
Table 101. Global Pertussis Vaccine Price by Type (2027-2032) & (USD/Doses)
Table 102. Global Pertussis Vaccine Sales by Application (2021-2026) & (M Doses)
Table 103. Global Pertussis Vaccine Sales by Application (2027-2032) & (M Doses)
Table 104. Global Pertussis Vaccine Sales Market Share by Application (2021-2026)
Table 105. Global Pertussis Vaccine Sales Market Share by Application (2027-2032)
Table 106. Global Pertussis Vaccine Revenue by Application (2021-2026) & (US$ Million)
Table 107. Global Pertussis Vaccine Revenue by Application (2027-2032) & (US$ Million)
Table 108. Global Pertussis Vaccine Revenue Market Share by Application (2021-2026)
Table 109. Global Pertussis Vaccine Revenue Market Share by Application (2027-2032)
Table 110. Global Pertussis Vaccine Price by Application (2021-2026) & (USD/Doses)
Table 111. Global Pertussis Vaccine Price by Application (2027-2032) & (USD/Doses)
Table 112. Key Raw Materials
Table 113. Raw Materials Key Suppliers
Table 114. Pertussis Vaccine Distributors List
Table 115. Pertussis Vaccine Customers List
Table 116. Pertussis Vaccine Industry Trends
Table 117. Pertussis Vaccine Industry Drivers
Table 118. Pertussis Vaccine Industry Restraints
Table 119. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pertussis Vaccine Product Image
Figure 5. Global Pertussis Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Pertussis Vaccine Market Size (2021-2032) & (US$ Million)
Figure 7. Global Pertussis Vaccine Sales (2021-2032) & (M Doses)
Figure 8. Global Pertussis Vaccine Average Price (USD/Doses) & (2021-2032)
Figure 9. Whole-cell Vaccines Product Image
Figure 10. Acellular Vaccines Product Image
Figure 11. 12 Months Below Product Image
Figure 12. 12 Months Above Product Image
Figure 13. Global Pertussis Vaccine Revenue Share by Manufacturers in 2025
Figure 14. Global Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
Figure 15. Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2025
Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 17. Global Pertussis Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 18. Global Pertussis Vaccine Sales by Region in 2025
Figure 19. Global Pertussis Vaccine Revenue by Region in 2025
Figure 20. North America Pertussis Vaccine Market Size by Country in 2025
Figure 21. North America Pertussis Vaccine Sales Market Share by Country (2021-2032)
Figure 22. North America Pertussis Vaccine Revenue Market Share by Country (2021-2032)
Figure 23. United States Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 24. Canada Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 25. Mexico Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Europe Pertussis Vaccine Market Size by Country in 2025
Figure 27. Europe Pertussis Vaccine Sales Market Share by Country (2021-2032)
Figure 28. Europe Pertussis Vaccine Revenue Market Share by Country (2021-2032)
Figure 29. Germany Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. France Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. U.K. Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Italy Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Russia Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Spain Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Netherlands Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Switzerland Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Sweden Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Poland Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Asia Pacific Pertussis Vaccine Market Size by Country in 2025
Figure 40. Asia Pacific Pertussis Vaccine Sales Market Share by Country (2021-2032)
Figure 41. Asia Pacific Pertussis Vaccine Revenue Market Share by Country (2021-2032)
Figure 42. China Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Japan Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. South Korea Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. India Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. Australia Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. Taiwan Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Southeast Asia Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. South America Pertussis Vaccine Market Size by Country in 2025
Figure 51. South America Pertussis Vaccine Sales Market Share by Country (2021-2032)
Figure 52. South America Pertussis Vaccine Revenue Market Share by Country (2021-2032)
Figure 53. Brazil Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Argentina Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Chile Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Middle East and Africa Pertussis Vaccine Market Size by Country in 2025
Figure 57. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2021-2032)
Figure 58. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2021-2032)
Figure 59. Egypt Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. South Africa Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. Israel Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Türkiye Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. GCC Countries Pertussis Vaccine Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Global Pertussis Vaccine Sales Market Share by Type (2021-2032)
Figure 65. Global Pertussis Vaccine Revenue Market Share by Type (2021-2032)
Figure 66. Global Pertussis Vaccine Price (USD/Doses) by Type (2021-2032)
Figure 67. Global Pertussis Vaccine Sales Market Share by Application (2021-2032)
Figure 68. Global Pertussis Vaccine Revenue Market Share by Application (2021-2032)
Figure 69. Global Pertussis Vaccine Price (USD/Doses) by Application (2021-2032)
Figure 70. Pertussis Vaccine Value Chain
Figure 71. Pertussis Vaccine Production Mode & Process
Figure 72. Direct Comparison with Distribution Share
Figure 73. Distributors Profiles
Figure 74. Pertussis Vaccine Industry Opportunities and Challenges
提及公司
Sanofi PasteurGSKMitsubishi Tanabe PharmaWuhan Institute of Biological ProductsWalvax BiotechnologyMinhai BiotechnologyKM BiologicsChengdu Institute of Biological Products
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們